Poking holes in Actel Corp (ACTL)

by Kris_Tuttle on January 21, 2009

We don’t focus much of our research horse­power on short ideas but often need some as a hedge in our port­fo­lios.  For­tu­nately we have been able to turn up some good ones in the past like Iron Moun­tain (IRM), Con­stant Con­tact (CTCT) and Syman­tec (SYMC.)

Actel is a lit­tle semi­con­duc­tor com­pany (2008 sales esti­mated at $218M) which is in the pro­gram­ma­ble chip seg­ment.  (Sim­i­lar com­pa­nies are Altera (ALTR), Xil­inx (XLNX), Atmel (ATML), Lat­tice Semi­con­duc­tor (LSCC) and Quick Logic (QUIK.))

There’s noth­ing fun­da­men­tally wrong with Actel and it looks like a decent-enough lit­tle com­pany. How­ever this global semi­con­duc­tor slow­down is not tak­ing any pris­on­ers and so far Actel esti­mates and the price of the stock sug­gest they will be spared.  The com­pany lacks high growth and doesn’t have par­tic­u­larly high margins.

The crux of the cur­rent prob­lem fac­ing Actel is that on Decem­ber 11, 2008 they pre-announced that results for the cur­rent quar­ter would be inline.  Two weeks later, on Decem­ber 24th, 2008, they announced the regret­table death of their CFO.  (We’re not sug­gest­ing that the CFO tragedy has any­thing to do with the story here but we know we need to men­tion it since it will show up in any news searches on this name.)

Actel is not a well-followed stock but for­ward esti­mates for the com­pany remain bull­ish and reflect rev­enue *growth* in the full year 2009 to $225M.    This appears to be impos­si­ble given that for­ward esti­mates for every other com­pany in and around Actel calls for a rev­enue decline of 20%.  A more real­is­tic sce­nario would prob­a­bly be for rev­enues in the $185M range and a small loss for the cur­rent year.

Indus­try experts might (might) sug­gest that Actel has some advan­tages in their abil­ity to make smaller units and/or con­sume less power per unit.  We can’t refute the claim and at least on the the sur­face the new “IGLOO” tech­nol­ogy from Actel looks quite solid.  How­ever noth­ing in the prod­uct fam­ily sup­ports a view that Actel rev­enues and mar­gins next year won’t be sub­stan­tially dif­fer­ent than competition.

From a stock supply/demand stand­point there lit­tle or no cur­rent short inter­est out­stand­ing in the shares.  Insid­ers have been sell­ing fairly steadily but not in huge vol­umes.  (31,000 shares sold in 12 trans­ac­tions ver­sus one 500 share pur­chase in the last six months.)

The com­pany does have about $5/share in cash which place a solid floor under the stock but prob­a­bly still mean­ing­fully below cur­rent prices.   Our esti­mate is that the stock should be trad­ing in the $8–9 range ver­sus the cur­rent $11–12.  That poten­tial doesn’t put it at the top of our list but in a mar­ket where shorts are needed it seems to be a decent candidate.

[We have a small short posi­tion in ACTL at the time of this writing.]

Comments on this entry are closed.

Previous post:

Next post: